Unibest 优贝德
← Back to patent-cliff list

CAS 132201-33-3

(2R,3S)-2-Hydroxy-3-phenyl-3-(phenylformamido)propanoic acid

Codes:101438-23-a、(V)101438-37-a、(IV)101438-42-a、(VIII)101438-50-a、(IX)101438-66-a

Application context (from source-drug indications)

乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Paclitaxel/Encequidar mesylate优化路线steps: 5total yield: /
methyl (2R,3R)-3-phenyloxirane-2-carboxylate→methyl 3-azido-2-hydroxy-3-phenylpropanoate→methyl 3-azido-2-oxo-3-phenylpropanoate→methyl (2R)-3-azido-2-hydroxy-3-phenylpropanoate→methyl (2R,3S)-3-azido-2-hydroxy-3-phenylpropanoate→(2R,3S)-2-Hydroxy-3-phenyl-3-(phenylformamido)propanoic acid
Paclitaxel/Encequidar mesylate优化路线steps: 2total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.